TRAF3 can interact with GMEB1 and modulate its anti-apoptotic function

George Kotsaris,Eudoxia G Ηatzivassiliou,Dimitrios Koutsoubaris,George Malamas,Despoina Kerselidou,Dimitrios A Garyfallos,Elena Constantinou

doi:10.1186/s40709-020-00117-2

Abstract

BackgroundMembers of Tumor Necrosis Factor (TNF) Receptor-Associated Factors (TRAFs) family interact with the cytoplasmic tails of TNF receptor family members to mediate signal transduction processes. TRAF3 has a major immunomodulatory function and TRAF3 deficiency has been linked to malignancies, such as multiple myeloma and lymphoid defects. In order to characterize the molecular mechanisms of TRAF3 signaling, the yeast two-hybrid system was used to identify proteins that interact with TRAF3.ResultsThe yeast two-hybrid screen of a human B cell cDNA library with TRAF3 as bait, identified Glucocorticoid Modulatory Element-Binding Protein 1 (GMEB1) as a TRAF3-interacting protein. Previous studies indicated that GMEB1 functions as a potent inhibitor of caspase activation and apoptosis. The interaction of TRAF3 and GMEB1 proteins was confirmed in mammalian cells lines, using immunoprecipitation assays. The RING and TRAF-C domains of TRAF3 were not essential for this interaction. The overexpression of TRAF3 protein enhanced the anti-apoptotic function of GMEB1 in HeLa cells. On the other hand, downregulation of TRAF3 by RNA interference decreased significantly the ability of GMEB1 to inhibit apoptosis. In addition, LMP1(1–231), a truncated form of the EBV oncoprotein LMP1, that can interact and oligomerize with TRAF3, was also able to cooperate with GMEB1, in order to inhibit apoptosis.ConclusionsOur protein-interaction experiments demonstrated that TRAF3 can interact with GMEB1, which is an inhibitor of apoptosis. In addition, cell viability assays showed that overexpression of TRAF3 enhanced the anti-apoptotic activity of GMEB1, supporting a regulatory role of TRAF3 in GMEB1-mediated inhibition of apoptosis. Better understanding of the molecular mechanism of TRAF3 function will improve diagnostics and targeted therapeutic approaches for TRAF3-associated disorders.

Highlights

Members of Tumor Necrosis Factor (TNF) Receptor-Associated Factors (TRAFs) family interact with the cytoplasmic tails of TNF receptor family members to mediate signal transduction processes
Our protein-interaction experiments demonstrated that TRAF3 can interact with Glucocorticoid Modulatory Element-Binding Protein 1 (GMEB1), which is an inhibitor of apoptosis
To confirm the ability of TRAF3 to interact with GMEB1, it was examined whether the two proteins could be co-immunoprecipitated in mammalian cells

Summary

Introduction

Members of Tumor Necrosis Factor (TNF) Receptor-Associated Factors (TRAFs) family interact with the cytoplasmic tails of TNF receptor family members to mediate signal transduction processes. TRAF3 has a major immunomodulatory function and TRAF3 deficiency has been linked to malignancies, such as multiple myeloma and lymphoid defects. In order to characterize the molecular mechanisms of TRAF3 signaling, the yeast two-hybrid system was used to identify proteins that interact with TRAF3. Mutations that inhibit the function of TRAF3 lead to constitutively active NF-κB in patients with multiple myeloma [7]. TRAF3 inactivating mutations have been linked to multiple types of B-cell lymphomas [11,12,13]. Better characterization of the molecular mechanisms of TRAF3 function will improve diagnostics and lead to new therapeutic approaches for TRAF3 associated disorders

Methods

Results

Discussion

Conclusion